Persistent Adverse Perinatal Outcomes among Pregnancies with Gestational Diabetes in the United States
American Journal of Perinatology · 25.09.2026
DOI: 10.1055/a-2957-5259 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 25.09.2026. Verfasst von Amy M Valent und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health and Science University School of Medicine, Department of Obstetrics and Gynecology, Oregon, United States, Portland. Die Arbeit nennt 20 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study aimed to evaluate the prevalence of large-for-gestational age (LGA) births and hypertensive disorders of pregnancy (HDP) among pregnant individuals with gestational diabetes mellitus (GDM) following the 2014 U.S. Preventive Services Task Force (USPSTF) universal screening recommendation. We analyzed linked U.S. birth and infant death datasets for singleton, non-anomalous births delivered between 230/7 and 426/7 weeks' gestation from 2014 to 2022. Multivariate Poisson regression models estimated the independent association between GDM and LGA, small for gestational age (SGA), or HDP. Among the 31,791,459 total births included in the analysis, 6.8% had GDM, and the LGA prevalence declined from 17.9% in 2014 to 14.9% in 2022 (risk ratio [RR] 0.83; 95% confidence interval [CI] 0.82–0.84; rate difference − 3.06%) without an increase in rates of SGA infants. However, the overall frequency of LGA among pregnancies complicated by GDM was higher than in pregnancies that were not complicated by GDM in the United States during this study period ([GDM] 16.2% vs. [non-GDM] 10.8%, p < 0.001; RR 1.53 [95% CI 1.52–1.54]). In contrast, HDP prevalence increased from 11.1 to 15.5% during the same period among pregnancies complicated by GDM (RR 1.40; 95% CI 1.38–1.42; rate difference 4.46%). GDM remained independently associated with LGA (adjusted RR [aRR] 1.34 [95% CI 1.33–1.34]) and HDP (aRR 1.67 [1.66–1.68]). While universal GDM screening and current management strategies have reduced LGA at the population level, LGA still remains persistently higher than in non-GDM pregnancies, and HDP rates continue to rise. Future studies should focus on innovative interventions to improve outcomes.
Autor:innen und Institutionen
- Oregon Health and Science University School of Medicine, Department of Obstetrics and Gynecology, Oregon, United States, Portland.
- University of Colorado Anschutz Medical Campus, College of Nursing, Colorado, United States, Denver.
- University of Colorado at Denver - Anschutz Medical Campus, School of Medicine, Department of Medicine, Colorado, United States, Aurora.
- Children's Hospital Colorado, Anschutz Medical Campus, Colorado, United States, Aurora.
ORCID-Profile: Amy M Valent
Zitieren
APA
Valent, A. M., Garg, B., Caughey, A. B., & Hernandez, T. L. (2026). Persistent Adverse Perinatal Outcomes among Pregnancies with Gestational Diabetes in the United States. American Journal of Perinatology. https://doi.org/10.1055/a-2957-5259
Vancouver
Valent AM, Garg B, Caughey AB, Hernandez TL. Persistent Adverse Perinatal Outcomes among Pregnancies with Gestational Diabetes in the United States. American Journal of Perinatology. 2026. doi:10.1055/a-2957-5259
BibTeX
@article{Valent2026,
author = {Valent, Amy M and Garg, Bharti and Caughey, Aaron B and Hernandez, Teri L},
title = {Persistent Adverse Perinatal Outcomes among Pregnancies with Gestational Diabetes in the United States},
journal = {American Journal of Perinatology},
year = {2026},
doi = {10.1055/a-2957-5259}
}
EUVIMED